EXPOSURE AND SCHEDULE DEPENDENCY OF ETOPOSIDE IN NEUROBLASTOMA AND LEUKEMIA-CELLS IN-VITRO

被引:11
|
作者
LOWIS, SP [1 ]
NEWELL, DR [1 ]
PEARSON, ADJ [1 ]
机构
[1] UNIV NEWCASTLE UPON TYNE,DEPT CHILD HLTH,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND
关键词
ETOPOSIDE; NEUROBLASTOMA; L1210; CELL CYCLE; SCHEDULE DEPENDENCY;
D O I
10.1016/0959-8049(95)00026-F
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using an in vitro clonogenic assay system, we examined the relationship between concentration, duration and schedule of exposure to etoposide and cytotoxicity in three cell lines. Two cell lines (SK-N-SH and IMR 32) were derived from human neuroblastomas, and one (L1210) was the original murine leukaemia cell line used to define schedule dependency of etoposide in vivo. Cytotoxicity was found to be determined by the product of concentration and duration of exposure over a 120-fold range of durations and a 100-fold range of concentrations. No difference in cytotoxicity was seen following equivalent exposure either continuously or in two separate intervals. In one cell line, exposure to etoposide when at confluence led to a highly resistant subpopulation comprising 10-15% of the entire cell number. This did not seem to be associated with any difference in the rate of etoposide efflux from cells preloaded with H-3-etoposide. We conclude that etoposide does not show schedule dependency in vitro, but cytotoxicity is related to total exposure to etoposide. The schedule dependency seen in vivo may possibly arise from host pharmacokinetic factors.
引用
收藏
页码:622 / 626
页数:5
相关论文
共 50 条
  • [1] GROWTH-STIMULATION OF FERRITIN OF HUMAN LEUKEMIA-CELLS IN-VITRO
    KIKYO, N
    HAGIWARA, K
    YAZAKI, Y
    OKABE, T
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (02) : 76 - 78
  • [2] EFFECTIVITY IN-VITRO OF HETEROLOGOUS RABBIT ANTISERA AGAINST MOUSE LEUKEMIA-CELLS
    MILLECK, J
    ARCHIV FUR GESCHWULSTFORSCHUNG, 1973, 42 (04): : 274 - 284
  • [3] IN-VITRO STUDY OF THP-DOXORUBICINE EFFLUX FROM HUMAN LEUKEMIA-CELLS
    PIGNON, B
    MORIANI, H
    VILQUE, JP
    MILLOT, JM
    LARTIGUE, B
    ETIENNE, JC
    POTRON, G
    MANFAIT, M
    BLOOD, 1993, 82 (10) : A545 - A545
  • [4] IDENTIFICATION OF THE RET PROTOONCOGENE PRODUCTS IN NEUROBLASTOMA AND LEUKEMIA-CELLS
    TAKAHASHI, M
    BUMA, Y
    TANIGUCHI, M
    ONCOGENE, 1991, 6 (02) : 297 - 301
  • [5] CLONOGENIC POTENTIAL OF MYELOID-LEUKEMIA CELLS IN-VITRO IS RESTRICTED TO LEUKEMIA-CELLS EXPRESSING THE CD34 ANTIGEN
    YIN, MI
    SILVESTRI, FF
    BANAVALI, SD
    GOPAL, V
    HULETTE, BC
    KUVELKAR, RB
    YOUNG, AN
    MAYERS, G
    PREISLER, HD
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (16) : 2279 - 2283
  • [6] INVOLVEMENT OF OXYGEN RADICALS IN THE DIFFERENTIATION OF RAT MYELOMONOCYTIC LEUKEMIA-CELLS IN-VITRO AND IN-VIVO
    KOBAYASHI, M
    NISHIHARA, J
    FUJII, Y
    MAEDA, H
    HOSOKAWA, M
    TAKEICHI, N
    LEUKEMIA RESEARCH, 1994, 18 (03) : 199 - 203
  • [7] ELECTROGENESIS IN MOUSE NEUROBLASTOMA CELLS IN-VITRO
    NELSON, PG
    PEACOCK, JH
    AMANO, T
    MINNA, J
    JOURNAL OF CELLULAR PHYSIOLOGY, 1971, 77 (03) : 337 - +
  • [8] CHEMOSENSITIVITY OF MOUSE NEUROBLASTOMA CELLS IN-VITRO
    PEACOCK, JH
    NELSON, PG
    JOURNAL OF NEUROBIOLOGY, 1973, 4 (04): : 363 - 374
  • [9] DIFFERENTIATION OF PROMYELOCYTIC LEUKEMIA-CELLS HL-60 INDUCED BY DAIDZEIN IN-VITRO AND IN-VIVO
    JING, YK
    NAKAYA, K
    HAN, R
    ANTICANCER RESEARCH, 1993, 13 (04) : 1049 - 1054
  • [10] CAMPTOTHECIN CYTOTOXIC EFFECTS IN-VITRO - DEPENDENCY ON EXPOSURE DURATION AND DOSE
    HELSON, L
    HELSON, C
    AINSWORTH, S
    ANTI-CANCER DRUGS, 1995, 6 (04) : 612 - 614